Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07127926
PHASE1
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
The primary objective of the study is to evaluate belumosudil pharmacokinetics of whole tablets and crushed tablets suspended in water in patients suffering from chronic graft-versus-host disease (cGVHD).
Official title: Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic Graft Versus Host Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2026-02-09
Completion Date
2027-12-31
Last Updated
2026-08-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Belumosudil
Given by PO
Locations (1)
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States